About methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate
methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate (PubChem CID 122595854) has the molecular formula C24H24BrClFN5O5S
and a molecular weight of 628.91 g/mol. Its IUPAC name is methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate.
Molecular Properties
| Compound Name | methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate |
| PubChem CID | 122595854 |
| Molecular Formula | C24H24BrClFN5O5S |
| Molecular Weight | 628.91 g/mol |
| Exact Mass | 627.04 |
| IUPAC Name | methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate |
| SMILES | COC(=O)NC1(C(=O)NCCCNS(=O)(=O)c2cc(-c3ncc(-c4ccc(Br)c(F)c4)[nH]3)ccc2Cl)CC1 |
| InChI | InChI=1S/C24H24BrClFN5O5S/c1-37-23(34)32-24(7-8-24)22(33)28-9-2-10-30-38(35,36)20-12-15(4-6-17(20)26)21-29-13-19(31-21)14-3-5-16(25)18(27)11-14/h3-6,11-13,30H,2,7-10H2,1H3,(H,28,33)(H,29,31)(H,32,34) |
| InChIKey | HEIQQRJEPAVISI-UHFFFAOYSA-N |
| XLogP | 3.97 |
| TPSA | 142.28 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 628.91 |
| LogP ≤ 5 | 3.97 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate?
The IUPAC name of methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate (CID 122595854) is methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate.
What is the SMILES notation for methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate?
The canonical SMILES for methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate is COC(=O)NC1(C(=O)NCCCNS(=O)(=O)c2cc(-c3ncc(-c4ccc(Br)c(F)c4)[nH]3)ccc2Cl)CC1.
What is the InChIKey of methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate?
The InChIKey is HEIQQRJEPAVISI-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H24BrClFN5O5S/c1-37-23(34)32-24(7-8-24)22(33)28-9-2-10-30-38(35,36)20-12-15(4-6-17(20)26)21-29-13-19(31-21)14-3-5-16(25)18(27)11-14/h3-6,11-13,30H,2,7-10H2,1H3,(H,28,33)(H,29,31)(H,32,34).
What are the key properties of methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate?
methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate has a molecular weight of 628.91 g/mol, XLogP of 3.97, 10 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[1-[3-[[5-[5-(4-bromo-3-fluorophenyl)-1H-imidazol-2-yl]-2-chlorophenyl]sulfonylamino]propylcarbamoyl]cyclopropyl]carbamate is sourced from PubChem (CID 122595854), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).